Martingale Asset Management’s Nuvalent NUVL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.67M Buy
16,321
+12,112
+288% +$1.23M 0.04% 385
2025
Q4
$423K Buy
4,209
+3
+0.1% +$296 0.01% 632
2025
Q3
$364K Hold
4,206
0.01% 665
2025
Q2
$321K Sell
4,206
-1,288
-23% -$94.2K 0.01% 691
2025
Q1
$390K Sell
5,494
-100
-2% -$7.82K 0.01% 645
2024
Q4
$438K Sell
5,594
-510
-8% -$47.6K 0.01% 629
2024
Q3
$624K Hold
6,104
0.01% 581
2024
Q2
$463K Buy
6,104
+2,750
+82% +$196K 0.01% 613
2024
Q1
$252K Buy
+3,354
New +$267K 0.01% 733

Other funds holding NUVL

Martingale Asset Management's NUVL Position: Q1 2026 in Review

Martingale Asset Management increased its Nuvalent (NUVL) stake by 288% in Q1 2026, buying an estimated $1.23M and bringing the position to 16,321 shares worth $1.67M. The position accounts for 0.04% of the portfolio, ranked #385.

Martingale Asset Management first reported a position in NUVL in Q1 2024 and has held it in 9 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Martingale Asset Management held 16,321 shares of Nuvalent worth $1.67M as of Q1 2026.
  • Martingale Asset Management bought 12,112 Nuvalent shares in Q1 2026, an estimated $1.23M.
  • Nuvalent made up 0.04% of Martingale Asset Management's portfolio in Q1 2026, its #385 holding.
  • Martingale Asset Management first reported a position in Nuvalent in Q1 2024 and has held it in 9 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Martingale Asset Management's 13F filing for Q1 2026, filed 13 May 2026.